Kenvue Inc. (KVUE) Price CAGR:-13.86%(TTM)
Over the latest trailing 12-month period, Kenvue Inc. (KVUE)'s price cagr is -13.86%. The comparable SPY value is +22.25%. Year-to-date price return is +6.29%. Price CAGR uses adjusted close price history and excludes dividends.
Over longer horizons, Kenvue Inc.'s Price CAGR averages -11.41% over 3 years. The price CAGR (Compound Annual Growth Rate) shows how Kenvue Inc.'s stock price has grown over various time periods. This measures pure price appreciation without including dividends.
KVUE Price CAGR Chart
Kenvue Inc. (KVUE)
KVUE Quarterly Price (YoY)
Price growth vs the same quarter one year earlier, last 9 quarters.
KVUE Price CAGR History
| Year | Start Price | End Price | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2026 | 24.06 | 17.17 | -6.89 | -28.64% | -28.64% |
| 2025 | 19.08 | 24.06 | +4.98 | +26.10% | +26.10% |
| 2024 | 26.90 | 19.08 | -7.82 | -29.07% | -29.07% |
Quarterly Price: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 18 | +6.8% | -12.0% |
| Q1 2026 | 17 | -0.1% | -28.1% |
| Q4 2025 | 17 | +6.3% | -19.2% |
| Q3 2025 | 16 | -22.5% | -29.8% |
| Q2 2025 | 21 | -12.7% | +15.1% |
| Q1 2025 | 24 | +12.3% | +11.7% |
| Q4 2024 | 21 | -7.7% | -0.8% |
| Q3 2024 | 23 | +27.2% | +15.2% |
| Q2 2024 | 18 | -15.3% | -31.2% |
| Q1 2024 | 21 | -0.3% | — |
| Q4 2023 | 22 | +7.2% | — |
| Q3 2023 | 20 | -24.0% | — |
| Q2 2023 | 26 | — | — |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry